Cumulative exposure to estrogen may increase the risk of migraine in women

Nora Stensland Bugge,Kjersti Grøtta Vetvik,Karl Bjørnar Alstadhaug,Tonje Braaten
DOI: https://doi.org/10.1177/03331024231225972
2024-01-14
Cephalalgia
Abstract:Cephalalgia, Volume 44, Issue 1, January 2024. BackgroundMigraine is a common disorder, particularly affecting women during their reproductive years. This female preponderance has been linked to exposure to female sex hormones.MethodsWe used self-reported data from women born in 1943–1965 enrolled in the Norwegian Women and Cancer Study to examine the differences between women with migraine and women without migraine in a prospective design with respect to both endogenous and exogenous female sex hormone exposure.ResultsIn total, 62,959 women were included in the study, of whom 24.8% reported previous migraine (n = 15,635). Using a Cox proportional hazards model, we found that higher age at menarche reduced the risk of migraine (hazards ratio (HR) = 0.96, 95% confidence interval (CI) = 0.95–0.98) and that oral contraceptive use and parity increased the risk of migraine (HR = 1.12, 95% CI = 1.06–1.18 and HR = 1.37, 95% CI = 1.29–1.46, respectively).ConclusionsOlder age at menarche appears to reduce migraine risk, whereas oral contraceptive use and having children appear to increase the risk. Further research is required to investigate the causality of these associations.
neurosciences,clinical neurology
What problem does this paper attempt to address?